Statin News and Research

RSS

Statins are drugs used to lower cholesterol. Your body needs some cholesterol to work properly. But if you have too much in your blood, it can stick to the walls of your arteries, narrowing or even blocking them.

Statins not effective in reducing dementia risk

According to a recently published study, the use of statins and other lipid-lowering agents by older adults is not associated with a reduced risk of Alzheimer's disease or other types of dementia.

12 Jul 2005

Statins not associated with a reduced risk of Alzheimer's disease or other types of dementia

The use of statins and other lipid-lowering agents by older adults was not associated with a reduced risk of Alzheimer's disease or other types of dementia, according to a study in the July issue of Archives of Neurology.

11 Jul 2005

Genes decide the shape you're in!

According to a study by researchers at the Lawrence Berkeley National Laboratory of identical twins, the reason why some people can eat all the chocolate and chips they want and not increase their cholesterol levels, is all down to their genes.

11 Jul 2005

Greater use of evidence-based medicine needed in US outpatient care

Although the quality of outpatient care in the United States has improved over the last decade, greater use of evidence-based medicine is needed, however, and quality of care is not significantly associated with the patient's racial or ethnic background, according to a study in the June 27 issue of Archives of Internal Medicine.

27 Jun 2005

Scientists have discovered how C-reactive protein is able to access endothelial cells

For the first time, scientists have discovered how C-reactive protein, or CRP, is able to access endothelial cells. The UC Davis researchers' findings will be published in the July issue of Arteriosclerosis, Thrombosis, and Vascular Biology, one of the American Heart Association's leading journals.

27 Jun 2005

First blood test to help predict a patient's risk for ischemic stroke

The U.S. Food and Drug Administration (FDA) has approved the first blood test designed to help predict a patient's risk for ischemic stroke, the most common type of stroke and one of the nation's leading causes of long-term disability affecting approximately 700,000 people per year.

19 Jun 2005

Novel targets found for the development of drugs to complement, or replace, statins

A team of investigators from the Uppsala Branch of the Ludwig Institute for Cancer Research (LICR) and Harvard Medical School has uncovered novel targets for the development of drugs that would potentially complement, or replace, statins in treating heart disease.

8 Jun 2005

Diabetes knowledge has little effect on improving outcomes

A new study by Duke Clinical Research Institute researchers finds little relationship between what a diabetic patient knows about the disease and control of its associated cardiovascular risk factors or how well the patient ultimately fares.

3 Jun 2005

Ageing and Health publication by the Medical Research Council highlights groundbreaking work on the ageing process

With life expectancy increasing worldwide, a new 'Ageing and Health' (PDF) publication by the Medical Research Council (MRC) highlights groundbreaking work on the ageing process, which could help elderly people not only live longer, but also lead healthier and happier lives.

2 Jun 2005

Under prescribing of statins puts more people at risk of premature death

A new study out of Stanford School of Medicine says that cholesterol-lowering drugs known as statins that can help prevent heart disease are still underprescribed for many at-risk patients.

31 May 2005

Most serious side effects in statins may be higher in one of the newest drugs, rosuvastatin (Crestor)

A post-market analysis of cholesterol-lowering drugs called statins indicates that some of the most serious side effects may be higher in one of the newest drugs, rosuvastatin (Crestor). The drug is the strongest statin available because it has the greatest effect per milligram on low-density lipoprotein ("bad" cholesterol).

26 May 2005

Statin drugs prescribed for heart disease also reduce the risk of colon cancer

According to new research released this week people taking statin drugs to control the progression of heart disease may be getting the extra benefit of protection from colorectal cancer.

25 May 2005

New cholesterol drug Crestor causes safety concerns

A study by a leading medical journal has concluded that AstraZeneca's controversial drug Crestor produces more than twice as many side effects as other common cholesterol lowering treatments.

24 May 2005

Statin chemoprevention with minimal surveillance could prevent 96 percent of colon cancers

Ulcerative colitis affects about one out of every 2,000 Americans, and after living with the disease for 30 years, nearly 22 percent of those people will develop colon cancer.

16 May 2005

Statins appear to lessen chance of developing breast cancer

According to a new study women who are taking the cholesterol-lowering drugs called statins, such as Lipitor or Mevacor, appear to have much less chance of developing breast cancer.

16 May 2005

Statin therapy is cost-effective for a wider range of individuals with vascular disease or diabetes than previously recognised

Current guidelines generally recommend the initiation of statin therapy when the estimated 10-year risk of a non-fatal heart attack or coronary death is at least 15-20%.

12 May 2005

Targeted Genetics announces new patent for Hyperlipidemia

Targeted Genetics Corporation announced today issuance of U.S. patent #6,887,463, entitled, "Methods and Compositions for Gene Therapy for the Treatment of Defects in Lipoprotein Metabolism."

11 May 2005

Drug lowers inflammatory markers associated with risk for heart attack

A preliminary study suggests that use of a drug that inhibits a specific protein in patients with certain genetic variants that increase their risk for heart attack reduced their levels of inflammatory markers associated with heart attack risk, according to a study in the May 11 issue of JAMA.

10 May 2005

Polypill improves survival rates for heart disease sufferers

A ‘polypill’ made up of a combination of drugs could extend the lives of thousands of patients with coronary heart disease, say researchers at The University of Nottingham.

10 May 2005

Drug combinations improve survival for patients with heart disease

Patients with coronary heart disease who take a combination of three specific drugs have a better chance of survival than those taking single drugs, finds a study in this week's BMJ.

5 May 2005